|
1
|
Zhao J, Jiang P and Zhang WD: Molecular
networks for the study of TCM Pharmacology. Brief Bioinform.
11:417–430. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ji HF, Li XJ and Zhang HY: Natural
products and drug discovery. Can thousands of years of ancient
medical knowledge lead us to new and powerful drug combinations in
the fight against cancer and dementia? EMBO Rep. 10:194–200.
2009.PubMed/NCBI
|
|
3
|
Longley DB, Allen WL and Johnston PG: Drug
resistance, predictive markers and pharmacogenomics in colorectal
cancer. Biochim Biophys Acta. 1766:184–196. 2006.PubMed/NCBI
|
|
4
|
Yan Y, Cook J, McQuillan J, Zhang G,
Hitzman CJ, Wang Y, Wiedmann TS and You M: Chemopreventive effect
of aerosolized polyphenon E on lung tumorigenesis in A/J mice.
Neoplasia. 9:401–405. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fang Y, Zhang Y, Chen M, Zheng H and Zhang
K: The active component of Hedyotis diffusa Willd. Chin Trad
Plant Med. 26:577–579. 2004.
|
|
6
|
Wu YG and Song LR: Shanghai Science and
Technology Press. Zhong Hua Ben Cao. 25:530–533. 1998.(In
Chinese).
|
|
7
|
Lin J, Wei L, Xu W, Hong Z, Liu X and Peng
J: Effect of Hedyotis Diffusa Willd extract on tumor
angiogenesis. Mol Med Rep. 4:1283–1288. 2011.
|
|
8
|
Lin J, Chen Y, Wei L, Chen X, Xu W, Hong
Z, Sferra TJ and Peng J: Hedyotis Diffusa Willd extract
induces apoptosis via activation of the mitochondrion-dependent
pathway in human colon carcinoma cells. Int J Oncol. 37:1331–1338.
2010.
|
|
9
|
Chen XZ, Cao ZY, Chen TS, Zhang YQ, Liu
ZZ, Su YT, Liao LM and Du J: Water extract of Hedyotis
Diffusa Willd suppresses proliferation of human HepG2 cells and
potentiates the anticancer efficacy of low-dose 5-fluorouracil by
inhibiting the CDK2-E2F1 pathway. Oncol Rep. 28:742–748. 2012.
|
|
10
|
Folkman J: Tumor angiogenesis: therapeutic
implications. N Engl J Med. 285:1182–1186. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Folkman J: Angiogenesis. Annu Rev Med.
57:1–18. 2006. View Article : Google Scholar
|
|
12
|
Fava RA, Olsen NJ, Spencer-Green G, Yeo
TK, Yeo KT, Berse B, Jackman RW, Senger DR, Dvorak HF and Brown JF:
Vascular permeability factor/endothelial growth factor (VPF/VEGF):
accumulation and expression in human synovial fluids and rheumatoid
synovial tissue. J Exp Med. 180:341–346. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
McLaren J, Prentice A, Charmock-Jones DS,
Millican SA, Muller KH, Sharkey AM and Smith SK: Vascular
endothelial growth factor is produced by peritoneal fluid
macrophages in endometriosis and is regulated by ovarian steroids.
J Clin Invest. 98:482–489. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shweiki D, Itin A, Soffer D and Keshet E:
Vascular endothelial growth factor induced by hypoxia may mediate
hypoxia-initiated angiogenesis. Nature. 359:843–845. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shalaby F, Rossant J, Yamaguchi TP,
Gertsenstein M, Wu XF, Britman ML and Schuh AC: Failure of
blood-island formation and vasculogenesis in Flk-1-deficient mice.
Nature. 376:62–66. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim KF, Li B, Winer J, Armanin M, Gillet
N, Philips HS and Ferrara N: Inhibition of vascular endothelial
growth factor-induced angiogenesis suppresses tumour growth in
vivo. Nature. 36:841–844. 1993. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yano S, Shinohara H, Herbst RS, Kuniyasu
H, Bucana CD, Ellis LM, Davis DW, McConkey DJ and Fidler IJ:
Expression of vascular endothelial growth factor is necessary but
not sufficient for production and growth of brain metastasis.
Cancer Res. 60:4959–4967. 2000.PubMed/NCBI
|
|
18
|
Li P, Zhang M, Ma WJ, Sun X and Jin FP:
Effects of brucine on vascular endothelial growth factor expression
and microvessel density in a nude mouse model of bone metastasis
due to breast cancer. Chin J Integr Med. 18:605–609. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shen AL, Hong F, Liu LY, Lin JM, Zhuang
QC, Hong ZF and Peng J: Effects of Pien Tze Huang (PTH) on
angiogenesis in vivo and in vitro. Chin J Integr Med. 18:431–436.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen LW, Lin J, Chen W and Zhang WP:
Effect of Chinese herbal medicine on patients with primary hepatic
carcinoma in III stage during perioperational period: a report of
42 cases. Zhongguo Zhong Xi Yi Jie He Za Zhi. 25:832–834. 2005.(In
Chinese).
|
|
21
|
Ellis LM and Hicklin DJ: VEGF-targeted
therapy: mechanisms of antitumour activity. Nat Rev Cancer.
8:579–591. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kerbel RS, Yu J, Tran J, Man S,
Viloria-Petit A, Klement G, Coomber BL and Rak J: Possible
mechanisms of acquired resistance to antiangiogenic drugs:
implications for the use of combination therapy approaches. Cancer
Metastasis Rev. 20:79–86. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Miller KD, Sweeney CJ and Sledge GW: Can
tumor angiogenesis be inhibited without resistance? EXS. 95–112.
2005.PubMed/NCBI
|
|
24
|
Carmeliet P: VEGF as a key mediator of
angiogenesis in cancer. Oncology. 69:4–10. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee S, Chen TT, Barber CL, Jordan MC,
Murdock J, Desai S, Ferrara N, Nagy A, Roos KP and Iruela-Arispe
ML: Autocrine VEGF signaling is required for vascular homeostasis.
Cell. 130:691–703. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kerbel RS: Tumor angiogenesis. N Engl J
Med. 358:2039–2049. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hisa T, Kimura Y, Takada K, Suzuki F and
Takigawa M: Shikonin: an ingredient of Lithospermum
erythrorhizon, inhibits angiogenesis in vivo and in vitro.
Anticancer Res. 18:783–790. 1998.
|
|
28
|
Yoon TJ, Yoo YC, Choi OB, Do MS, Kang TB,
Lee SW, Azuma I and Kim JB: Inhibitory effect of Korean mistletoe
(Viscum album coloratum) extract on tumour angiogenesis and
metastasis of haematogenous and non-haematogenous tumour cells in
mice. Cancer Lett. 97:83–91. 1995.
|
|
29
|
Alves De Paulo S, Teruszkin Balassiano I,
Henriques Silva N, Oliveira Castilho R, Coelho Kaplan MA, Currie
Cabral M and da Costa Carvalho MG: Chrysobalanus icaco L.
extract for antiangiogenic potential observation. Int J Mol Med.
5:667–669. 2000.
|
|
30
|
Kim MS, Lee YM, Moon EJ, Kim SE, Lee JJ
and Kim KW: Anti-angiogenic activity of torilin, a sesquiterpene
compound isolated from Torilis japonica. Inl J Cancer.
87:269–275. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kimura Y, Baba K and Okuda H: Inhibitory
effects of active substances isolated from Cassia
garrettiana heartwood on tumor growth and lung metastasis in
Lewis lung carcinoma-bearing mice (part 1). Anticancer Res.
20:2899–2906. 2000.PubMed/NCBI
|
|
32
|
Takaku T, Kimura Y and Okuda H: Isolation
of an antitumor compound from Agaricus blazei Murill and its
mechanism of action. J Nutr. 131:1409–1413. 2001.PubMed/NCBI
|
|
33
|
Casaletto JB and McClatchey AI: Spatial
regulation of receptor tyrosine kinases in development and cancer.
Nat Rev Cancer. 12:387–400. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sastry SK and Elferink LA: Checks and
balances: interplay of RTKs and PTPs in cancer progression. Biochem
Pharmacol. 82:435–440. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Casanovas O, Hicklin DJ, Bergers G and
Hanahan D: Drug resistance by evasion of antiangiogenic targeting
of VEGF signaling in late-stage pancreatic islet tumors. Cancer
Cell. 8:299–309. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Faivre S, Ronot M, Dreyer C, Serrate C,
Hentic O, Bouattour M, Bruno O, Couvelard A, Vilgrain V and Raymond
E: Imaging response in neuroendocrine tumors treated with targeted
therapies: the experience of sunitinib. Target Oncol. 7:127–133.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Escudier B, Szczylik C, Porta C and Gore
M: Treatment selection in metastatic renal cell carcinoma: expert
consensus. Nat Rev Clin Oncol. 9:327–337. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zheng LP, Hu HX, Lin W, Huang YM, Zhao JY
and Chen WL: The effect of serum of Jiedu Xiaozheng Yin on
proliferation of gastric carcinoma cell line. Pharmacology and
Clinics of Chinese Materia Medica. 25:91–93. 2009.(In Chinese).
|
|
39
|
Chen XZ and Du J: The effect of Jiedu
Xiaozheng drink on HepG2 cells mitochondrial membrane potential.
Journal of Fujian University of TCM. 19:22–23. 2009.(In
Chinese).
|
|
40
|
Chen L, Zheng C and Du J: Study on
antitumor mechanism of Qingre Xiaozheng drink by molecular docking
method. Clin Pharmacol Ther. 12:324–328. 2007.
|
